The fears that the downward spiral of the capital markets during the financial crisis that occurred in 2008 would be repeated in the wake of last week's "Black Monday" are, for the time being, in the rearview mirror. more »
What's in a name? A core drug substance and a four-letter alphabet soup suffix. That's the FDA's proposal for nonproprietary, or "proper," names for reference biologics and biosimilars.
- Biotech sector remains solid after meltdown of general markets
- Salka's career traverses genomics jungle, turns new 'phage' at Ampliphi
- Alnylam/Medco PCSK9 for LDL-C hot in phase I; twice-yearly dose near?
- Pyruvates of the Caribbean slay tumors
- China's Burning Rock raises $23M, inks NGS alliance with Illumina
- Korea's Bioepis eyeing rare Nasdaq listing as it advances biosimilars
- Compulsory license case not strong enough, Indian officials suggest
- China's reforms aim to speed drug approvals
- Androgen receptor finding key to prostate cancer drug design
- India's pharma industry continues to struggle: CRO slapped by FDA
The fears that the downward spiral of the capital markets during the financial crisis that occurred in 2008 would be repeated in the wake of last week's "Black Monday" are, for the time being, in the rearview mirror. In fact, the markets have rebounded strongly and now seem poised to remain positive for the final months of the year, although it is predicted there will be some turbulence along the way.
In genomewide association studies (GWAS), a variant in the gene FTO is the strongest obesity-correlated signal in the human genome.
Since it was first flagged by GWAS seven years ago, though, why FTO is so strongly linked to obesity has remained a puzzle.
Now, scientists have dissected the cellular circuitry that is affected by FTO. Their work both suggests new obesity targets and could serve as a general roadmap for how to understand the effects of variants in noncoding regions of the genome.READ MORE »
- Pyruvates of the Caribbean slay tumors »
- New insights into relationship between pain and depression »
- Androgen receptor finding key to prostate cancer drug design »
- New antigens could provide broader influenza protection »
- Unleashing immune system moves from cancer to neurodegeneration »
- GITR antibody-mediated cancer immunotherapies mechanism described »
- Method expands adaptive data analysis »
- Chemical reprogramming can transform skin cells into neurons »
- Aging thymus is felled by free radicals in support cells »
- The next episode of the American horror storyJuly 24, 2015 | 9:10 PM | Posted by: Mari Serebrov
- Utopia, dystopia: Separating truth from fiction in bioethics discussionsJune 03, 2015 | 12:05 AM | Posted by: Jennifer Boggs
- A world of intrigue, from Missoula to Mars: BioWorld’s 9th Annual Summer Reading ListMay 26, 2015 | 6:31 PM | Posted by: Marie Powers
- You’ve come a long way, baby, but still a long way to goMay 04, 2015 | 2:44 PM | Posted by: Mari Serebrov
- As researchers unlock the brain’s mysteries, let’s not overlook the real questionsApril 27, 2015 | 4:35 PM | Posted by: Marie Powers
Partners in Focus
Cast Your Vote
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter